检索结果-南通市图书馆

Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial

引用

Chinese Journal of Cancer 2017年第11期36卷 609-617页

作者： Kyung-Hee Lee Tae Won Kim Jung-Hun Kang Jin-Soo Kim Jin-Seok Ahn Sun-young Kim Hwan-Jung Yun young-Jun eum Sung Ae Koh Min Kyoung Kim Yong Sang Hong Jeong Eun Kim Gyeong-Won Lee Department of Hematology-Oncology Yeungnam University Medical Center Daegu 42415 South Korea Department of Oncology Asan Medical Center University of Ulsan Seoul 05505 South Korea Department of Hematology-Oncology Gyeongsang National University Hospital Jinju 52727 South Korea Department of Internal Medicine SMG-SNU Boramae Medical Center Seoul 07061 South Korea Division of Hematology-Oncology Department of Medicine Samsung Medical Center Seoul 06351 South Korea Department of Hematology.Oncology National Cancer Center Ilsan 10408 South Korea Department of Hematology-Oncology Chungnam National University Hospital Daejeon 35015 South Korea Medical Affairs Mundipharma Korea Ltd Seoul 04637 South Korea Department of Oncology Asan Medical Center University of Ulsan College of Medicine 388.1 Pungnap-dong Songpa-gu Seoul 138.736 South Korea

Background: Controlled-release oxycodone/naloxone(OXN-CR) maintains the effect of opioid-induced analgesia through oxycodone while reducing the occurrence rate of opioid-induced constipation through naloxone. The present study was designed to assess the non-inferiority of OXN-CR to controlled-release oxycodone(OX-CR) for the control of cancer-related pain in Korean ***: In this randomized, open-labeled, parallel-group, phase IV study, we enrolled patients aged 20 years or older with moderate to severe cancer-related pain [numeric rating scale(NRS) pain score ≥4] from seven Korean oncology/hematology centers. Patients in the intention-to-treat(ITT) population were randomized(1:1) to OXNCR or OX-CR groups. OXN-CR was administered starting at 20 mg/10 mg per day and up-titrated to a maximum of80 mg/40 mg per day for 4 weeks, and OX-CR was administered starting at 20 mg/day and up-titrated to a maximum of 80 mg/day for 4 *** primary efficacy endpoint was the change in NRS pain score from baseline to week4, with non-inferiority margin of-1.5. Secondary endpoints included analgesic rescue medication intake, patientreported change in bowel habits, laxative intake, quality of life(QoL), and safety ***: Of the ITT population comprising 128 patients, 7 with missing primary efficacy data and 4 who violated the eligibility criteria were excluded from the efficacy analysis. At week 4, the mean change in NRS pain scores was not significantly different between the OXN-CR group(n = 58) and the OX-CR group(n = 59)(-1.586 vs.-1.559,P = 0.948). The lower limit of the one-sided 95% confidence interval(-0.776 to 0.830) for the difference exceeded the non-inferiority margin(P < 0.001). The OXN-CR and OX-CR groups did not differ significantly in terms of analgesic rescue medication intake, change in bowel habits, laxative intake, QoL, and safety ***: OXN-CR was non-inferior to OX-CR in terms of pain reduction after 4 weeks of treatmen

关键词： Constipation Naloxone Oxycodone Quality of life Safety

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Non-surgical treatment of post-surgical bile duct injury: Clinical implications and outcomes

引用

World Journal of Gastroenterology 2014年第22期20卷 6924-6931页

作者： young Ook eum Joo Kyung Park Jaeyoung Chun Sang-Hyub Lee Ji Kon Ryu Yong-Tae Kim Yong-Bum Yoon Chang Jin Yoon Ho-Seong Han Jin-Hyeok Hwang Department of Internal medicine Cheongju St. Mary's HospitalChungcheongbuk-do 360-568South Korea Department of Internal Medicine Seoul National University Hospital Seoul National University College of Medicine Seoul 110-744South Korea Department of Internal Medicine Seoul National University College of Medicine Seoul National University Bundang Hospital Gyeonggi-do 463-707South Korea Department of Radiology Seoul National University Bundang HospitalGyeonggi-do 463-707South Korea Department of Surgery Seoul National University Bundang HospitalGyeonggi-do 463-707South Korea

AIM: To investigate the prognostic factors determining the success rate of non-surgical treatment in the management of post-operative bile duct injuries (BDIs).

关键词： Endoscopic retrograde cholangiography Percutaneous transhepatic cholangiography Percutaneous transhepatic biliary drainage Bile duct Biliary stricture.

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

羟考酮/纳洛酮控释片与羟考酮控释片治疗韩国癌性疼痛患者的疗效及安全性的随机对照研究

引用

癌症 2018年第5期37卷 179-187页

作者： Kyung-Hee Lee Tae Won Kim Jung-Hun Kang Jin-Soo Kim Jin-Seok Ahn Sun-young Kim Hwan-Jung Yun young-Jun eum Sung Ae Koh Min Kyoung Kim Yong Sang Hong Jeong Eun Kim Gyeong-Won Lee Department of Hematology-Oncology Yeungnam University Medical Center Department of Oncology Asan Medical Center University of Ulsan Department of Oncology Asan Medical Center University of Ulsan College of Medicine Department of Hematology-Oncology Gyeongsang National University Hospital Department of Internal Medicine SMG-SNU Boramae Medical Center Division of Hematology-Oncology Department of Medicine Samsung Medical Center Department of Hematology-Oncology National Cancer Center Department of Hematology-Oncology Chungnam National University Hospital Medical Affairs Mundipharma Korea Ltd

背景与目的羟考酮/纳洛酮控释片(controlled?release oxycodone/naloxone,OXN?CR)通过羟考酮发挥阿片类药物诱导的镇痛效果,同时纳洛酮可降低阿片类药物引起的便秘的发生率。本研究旨在评价与羟考酮控释片(controlled?release oxycodone... 详细信息

背景与目的羟考酮/纳洛酮控释片(controlled?release oxycodone/naloxone,OXN?CR)通过羟考酮发挥阿片类药物诱导的镇痛效果,同时纳洛酮可降低阿片类药物引起的便秘的发生率。本研究旨在评价与羟考酮控释片(controlled?release oxycodone,OX?CR)相比,OXN?CR在控制韩国患者癌性疼痛中的非劣效性。方法本项随机、开放标签、平行分组、IV期研究中,我们从韩国的7个肿瘤学/血液学中心招募了年龄20岁及以上、具有中重度癌性疼痛的患者[疼痛数字评价量表(numeric rating scale,NRS)疼痛评分≥4分]。意向治疗人群(intention天20 mg/10 mg,每天最大?to用?treat,ITT)随机(1:1)分为OXN?CR和OX?CR组。OXN?CR组:起始用药量为每药量80 mg/40 mg,用药4周。OX?CR组:起始用药量为20 mg/d,最大用药量为80 mg/d,用药4周。本研究的主要疗效终点为NRS疼痛评分从基线到第4周的变化,其非劣效性界值为-1.5。次要终点包括应急镇痛药摄入量、患者报告的排便习惯改变、缓泻药摄入量、生活质量(quality of life,QoL)及安全性评价。结果 128例患者组成的ITT人群中,7例因缺失主要疗效数据、4例因不符合资格标准被排除疗效分析。在第4周时,OXN?CR组(n=58)和OX?CR组(n=59)患者NRS疼痛评分的平均变化无显著性差异(-1.586 vs.-1.559,P=0.948)。组间差异的单侧95%置信区间(-0.776-0.830)的下限超过非劣效性边界(P <0.001)。OXN?CR和OX?CR两组患者在应急镇痛药摄入量、排便习惯改变、缓泻药摄入量、QoL和安全性评价方面均无显著差异。结论就治疗4周后减轻患者疼痛的效果而言,OXN?CR的疗效非劣于OX?CR,两者具有相似的安全性。对于OXN?CR在长期疼痛控制和缓解便秘方面的疗效,则需在更多韩国癌性疼痛患者人群中开展进一步的研究。

关键词：便秘纳洛酮羟考酮生活质量安全性

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

用于工业废水处理及回收的耐污染膜系统

引用

水处理信息报导 2016年第3期 37-37页

作者： Joon Min, Ph.D. BKT, Anaheim, CA Daeik Kim BKT United Anaheim, CA young eum Gi Park FMC Daejon Korea Sang Kim FMC Daejon Korea Jang Kim BKT Korea.Seoul

膜技术用于工业废水处理过程中会出现的主要问题是污染。BKT＇s公司开发了一种名叫FMX的耐污染膜系统可以解决这些问题。FMX膜系统已经实现工业规模运行，用于甲基纤维处理，沼气厂的厌氧消化污水处理以及畜牧废物处理。该技术还在几十... 详细信息

膜技术用于工业废水处理过程中会出现的主要问题是污染。BKT＇s公司开发了一种名叫FMX的耐污染膜系统可以解决这些问题。FMX膜系统已经实现工业规模运行，用于甲基纤维处理，沼气厂的厌氧消化污水处理以及畜牧废物处理。该技术还在几十家工业企业和商业企业现场进行了测试，包括废的发动机油处理，纳米级银回收，啤酒发酵工艺回收，渗滤液处理，食品垃圾处理，乳胶生产废水处理，酒糟废物或任何普通膜不能使用的领域。FMX使用任何膜材料，包括各种供应商提供的Ⅷ、UF或NF。

关键词：工业废水处理膜系统耐污染银回收生产废水处理废物处理水处理过程渗滤液处理

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

National trends in alcohol and substance use among adolescents from 2005 to 2021:a Korean serial cross‑sectional study of one million adolescents

引用

World Journal of Pediatrics 2023年第11期19卷 1071-1081页

作者： Sangil Park Hyunju Yon Chae Yeon Ban Hyoin Shin Seounghyun eum Seung Won Lee Youn Ho Shin Jung UShin Ai Koyanagi Louis Jacob Lee Smith Chanyang Min AbdullahÖzgür Yeniova So young Kim Jinseok Lee Vlasta Hadalin Rosie Kwon Min Ji Koo Guillaume Fond Laurent Boyer Sunyoung Kim Jong Woo Hahn Namwoo Kim Eléa Lefkir Victoire Bondeville Sang Youl Rhee Jae Il Shin Dong Keon Yon Ho Geol Woo Department of Neurology Kyung Hee University Medical Center23 Kyungheedae‑roDongdaemun‑guSeoul 02447South Korea Department of Medicine Kyung Hee University College of MedicineSeoulSouth Korea Department of Precision Medicine Sungkyunkwan University School of MedicineSuwonSouth Korea Department of Pediatrics CHA Gangnam Medical CenterCHA University School of MedicineSeoulSouth Korea Department of Dermatology CHA Bundang Medical CenterCHA University School of MedicineSeongnamSouth Korea Research and Development Unit Parc Sanitari Sant Joan de DeuCIBERSAMISCIIIBarcelonaSpain Catalan Institution for Research and Advanced Studies(ICREA) Pg.Lluis CompanysBarcelonaSpain Faculty of Medicine University of Versailles Saint-Quentin-en-YvelinesMontigny‑le‑BretonneuxFrance Centre for Health Performance and WellbeingAnglia Ruskin UniversityCambridgeUK Center for Digital Health Medical Science Research InstituteKyung Hee University Medical CenterKyung Hee University College of MedicineSeoulSouth Korea Division of Gastroenterology Department of Internal MedicineFaculty of MedicineTokat Gaziosmanpaşa UniversityTokatTurkey Department of Otorhinolaryngology‑Head&Neck Surgery CHA Bundang Medical CenterCHA University School of MedicineSeongnamSouth Korea Department of Biomedical Engineering Kyung Hee UniversityYonginSouth Korea Faculty of Medicine University of LjubljanaLjubljanaSlovenia Department of Biomedical Engineering University of MichiganAnn ArborMIUSA Department of Human Biology University of TorontoTorontoONCanada AP-HM Aix-Marseille UniversityCEReSS-Health Service Research and Quality of Life CenterMarseilleFrance FondaMental Foundation CreteilFrance Department of Family Medicine Kyung Hee University College of MedicineSeoulSouth Korea Department of Pediatrics Seoul National University Bundang HospitalSeongnamSouth Korea Department of Neuropsychiatry Seoul National University HospitalSeoulSouth Korea Faculty of Medicine University of Rennes 1RennesFrance Department

Background Although previous studies have provided data on early pandemic periods of alcohol and substance use in adolescents,more adequate studies are needed to predict the trends of alcohol and substance use during recent periods,including the mid-pandemic *** study investigated the changes in alcohol and substance use,except tobacco use,throughout the pre-,early-,and mid-pandemic periods in adolescents using a nationwide serial cross-sectional survey from South *** Data on 1,109,776 Korean adolescents aged 13–18 years from 2005 to 2021 were obtained in a survey operated by the Korea Disease Control and Prevention *** evaluated adolescents’alcohol and substance consumption prevalence and compared the slope of alcohol and substance prevalence before and during the COVID-19 pandemic to see the trend *** define the pre-COVID-19 period as consisting of four groups of consecutive years(2005–2008,2009–2012,2013–2015,and 2016–2019).The COVID-19 pandemic period is composed of 2020(early-pandemic era)and 2021(midpandemic era).Results More than a million adolescents successfully met the inclusion *** weighted prevalence of current alcohol use was 26.8%[95%confidence interval(CI)26.4–27.1]from 2005 to 2008 and 10.5%(95%CI 10.1–11.0)in 2020 and *** weighted prevalence of substance use was 1.1%(95%CI 1.1–1.2)from 2005 to 2008 and 0.7%(95%CI 0.6–0.7)between 2020 and *** 2005 to 2021,the overall trend of use of both alcohol and drugs was found to decrease,but the decline has slowed since COVID-19 epidemic(current alcohol use:βdiff 0.167;95%CI 0.150–0.184;substance use:βdiff 0.152;95%CI 0.110–0.194).The changes in the slope of current alcohol and substance use showed a consistent slowdown with regard to sex,grade,residence area,and smoking status from 2005 to *** The overall prevalence of alcohol consumption and substance use among over one million Korean adolescents from the early and mid-stage(2020–2021)of the COVID

关键词： Alcohol Adolescent Corona virus disease 2019 South Korea Substance use

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：